Loading...

DRIO - DarioHealth Corp.

Analyst Upgrade Signal for 05-13-2022
Analyst Upgrade Signal: DRIO from Neutral to Buy by Alliance Global Partners
Price Target: $8.75



Stock Signal Information


Signal

Analyst Upgrade Stock
Report Date: 05-13-2022
Symbol: DRIO - DarioHealth Corp.
Sector: Healthcare
Industry: Diagnostics & Research
Analyst Upgrade Signal: DRIO from Neutral to Buy by Alliance Global Partners
Price Target: $8.75

  DRIO Technical Chart

Company Contact

DarioHealth Corp. (DRIO)
8 Hatokhen St.
CAESAREA, 3088900
Phone: 97236222929
Website: http://www.mydario.com
CEO: Mr. Erez Raphael


Company Profile

DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company's product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter. The Dario product is a digital diabetes management solution utilizing its technology delivered through a software application available for iPhone or Android and cloud-based data services with a blood glucose monitoring system device. Dario allows users to record, analyze, transmit and store various data points, such as glucose level, insulin and carbohydrate intake. It markets the Dario Smart Diabetes Management Solution in the Netherlands and New Zealand.